Functional genetics and experimental models of human cancer.

Abundant evidence supports the hypothesis that cancer arises from normal cells through the stepwise accumulation of genetic mutations. The study of cells obtained from patients with cancer has identified numerous molecules and pathways that fundamentally contribute to malignant transformation; however, cancer cell lines are often difficult to isolate or maintain, and the cell lines that are available for experimentation represent only a small subset of late-stage human cancers. Recent work has elucidated the role of telomerase in regulating human cell lifespan and has enabled the development of new experimental systems to study human cancer. This review highlights the recent progress in combining genetic methods and primary human cells to understand the role of specific genes and pathways in cancer pathogenesis.

[1]  W. Hahn,et al.  Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. , 2003, Cancer cell.

[2]  J. Robinson,et al.  Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Lange.  Protection of mammalian telomeres , 2002, Oncogene.

[4]  Robert A. Weinberg,et al.  Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.

[5]  A. Avilion,et al.  3 Telomerase Biochemistry and Regulation , 1994 .

[6]  W. Hahn,et al.  Identification of specific PP2A complexes involved in human cell transformation. , 2004, Cancer cell.

[7]  J. Decaprio,et al.  Cellular transformation by SV40 large T antigen: interaction with host proteins. , 2001, Seminars in cancer biology.

[8]  R. DePinho,et al.  Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.

[9]  K. Rundell,et al.  The role of the SV40 ST antigen in cell growth promotion and transformation. , 2001, Seminars in cancer biology.

[10]  R. DePinho,et al.  Constitutive telomerase expression promotes mammary carcinomas in aging mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Greider,et al.  Developmental and tissue-specific regulation of mouse telomerase and telomere length. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Blackburn,et al.  Telomere states and cell fates , 2000, Nature.

[13]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[14]  H. Ruley.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture , 1983, Nature.

[15]  D. Volsky,et al.  Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes , 1986, Molecular and cellular biology.

[16]  L. Hayflick.  Mortality and immortality at the cellular level. A review. , 1997, Biochemistry. Biokhimiia.

[17]  P. Khavari,et al.  CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis , 2002, Nature Medicine.

[18]  G. Hannon,et al.  Transformation of normal human cells in the absence of telomerase activation. , 2002, Cancer cell.

[19]  M. Robinson,et al.  Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.

[20]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[21]  J. Shay,et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.

[22]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.

[23]  V. Band,et al.  Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. McLendon,et al.  A genetically tractable model of human glioma formation. , 2001, Cancer research.

[25]  R. Sager.  Senescence as a mode of tumor suppression. , 1991, Environmental health perspectives.

[26]  C. Harley,et al.  Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.

[27]  K K Sanford,et al.  Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. , 1985, Science.

[28]  T. Hunter.  Cooperation between oncogenes , 1991, Cell.

[29]  W. Hahn,et al.  Abolition of Cyclin-Dependent Kinase Inhibitor p16Ink4a and p21Cip1/Waf1 Functions Permits Ras-Induced Anchorage-Independent Growth in Telomerase-Immortalized Human Fibroblasts , 2003, Molecular and Cellular Biology.

[30]  B. Hemmings,et al.  Regulation of protein kinase cascades by protein phosphatase 2A. , 1999, Trends in biochemical sciences.

[31]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[32]  Robert A. Weinberg,et al.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Agami,et al.  Ras interference as cancer therapy. , 2003, Seminars in cancer biology.

[34]  J. Willey,et al.  Malignant transformatin of human bronchial epithelial cells by radon-simulated α-particles , 1994 .

[35]  Huong T. T. Pham,et al.  Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene , 2001, Oncogene.

[36]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[37]  R. DePinho,et al.  Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. , 2003, Genes & development.

[38]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[39]  K. Rundell,et al.  Critical role for SV40 small-t antigen in human cell transformation. , 2001, Virology.

[40]  B. Leber,et al.  Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.

[41]  J. Minna,et al.  Alterations of the PPP2R1B gene in human lung and colon cancer. , 1998, Science.

[42]  M. Blasco,et al.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.

[43]  Robert A. Weinberg,et al.  Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .

[44]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[45]  D. Broccoli,et al.  Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[47]  William C Hahn,et al.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. , 2003, Cancer cell.

[48]  John R. W. Masters,et al.  Human cancer cell lines: fact and fantasy , 2000, Nature Reviews Molecular Cell Biology.

[49]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[50]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[51]  W. Hahn,et al.  Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.

[52]  S. Rafii,et al.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.

[53]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[54]  T. Jacks,et al.  Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.

[55]  W. Hahn,et al.  Immortalization and transformation of primary human airway epithelial cells by gene transfer , 2002, Oncogene.

[56]  C. Harley,et al.  Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes , 1994, Journal of virology.

[57]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[58]  C. Der,et al.  Distinct requirements for Ras oncogenesis in human versus mouse cells. , 2002, Genes & development.

[59]  G. Peters,et al.  Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. , 2003, Cancer cell.

[60]  J. Rhim,et al.  Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Henderson,et al.  Immortalization of human fibroblasts transformed by origin-defective simian virus 40 , 1987, Molecular and cellular biology.

[62]  M. Loda,et al.  Forkhead Transcription Factors Are Critical Effectors of Cell Death and Cell Cycle Arrest Downstream of PTEN , 2000, Molecular and Cellular Biology.

[63]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[64]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Kipling,et al.  Hypervariable ultra-long telomeres in mice , 1990, Nature.

[66]  M. Mathews,et al.  Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes , 1986, Molecular and cellular biology.

[67]  Andre Hoelz,et al.  Structural Evidence for Feedback Activation by Ras·GTP of the Ras-Specific Nucleotide Exchange Factor SOS , 2003, Cell.

[68]  S. Rafii,et al.  Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras , 2002, Oncogene.

[69]  Joseph R. Nevins,et al.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.